Genomic Vision S.A. buy melinda
Start price
23.03.16
/
50%
€8.60
Target price
26.09.16
€20.00
Performance (%)
-15.12%
End price
26.09.16
€7.30
Summary
This prediction ended on 26.09.16 with a price of €7.30. The price of Genomic Vision S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.12%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Genomic Vision S.A. | - | - | - | - |
| iShares Core DAX® | 2.831% | 1.236% | 14.788% | 17.647% |
| iShares Nasdaq 100 | 2.918% | 0.640% | 40.290% | 50.762% |
| iShares Nikkei 225® | 2.007% | -2.135% | 19.861% | 4.937% |
| iShares S&P 500 | 2.257% | 0.451% | 30.090% | 43.940% |
According to melinda what are the pros and cons of Genomic Vision S.A. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Genomic Vision S.A. diskutieren
Peignage moleculaire
technologie
(Laufzeit überschritten)
Stopped prediction by melinda for Genomic Vision S.A.
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.30
12.11.21
12.11.21
€0.50
12.11.22
12.11.22
-78.55%
13.11.22
13.11.22
Could be worthwhile Investment >10% per year
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.52
29.09.21
29.09.21
€0.75
29.09.22
29.09.22
-20.66%
09.10.21
09.10.21
Could be worthwhile Investment >10% per year
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.54
13.02.20
13.02.20
-
04.11.21
04.11.21
-2.46%
29.09.21
29.09.21
Could be worthwhile Investment >10% per year
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€7.46
17.03.16
17.03.16
€8.50
23.03.16
23.03.16
14.75%
23.03.16
23.03.16
Could be worthwhile Investment >10% per year